Pay in 4 interest-free payments of $5.18 Learn more
Ships within 48 hours · Estimated delivery Oct 25 - Oct 30
Discover the power of medical-grade peptide therapy
This combination addresses the primary concern with GLP-1 medications: significant lean tissue loss during aggressive caloric deficits
mitochondrial support add Feature Lean mass preservation Advanced Recomp Stack Enhanced via GH + IGF-1 CagriSema Some amylin signal Retatrutide Solo Limited - deficit risk remains Reta + MOTS-c Limited Feature Injection burden Advanced Recomp Stack 1 weekly + daily CJC/Ipa CagriSema 1 weekly combined Retatrutide Solo 1 weekly Reta + MOTS-c 1 weekly + 2-3x weekly MOTS-c Feature Complexity Advanced Recomp Stack High (3 compounds, 3 vials) CagriSema Low (single combo) Retatrutide Solo Low (single) Reta + MOTS-c Moderate Feature Cost Advanced Recomp Stack High CagriSema Moderate Retatrutide Solo Moderate Reta + MOTS-c Moderate-high Feature Evidence level Advanced Recomp Stack Phase 3 (reta) + PK (CJC/Ipa)
Liraglutide 3.0 mg improved postprandial glycemia to a greater extent than liraglutide 1.8 mg
(5) Spiering BA, et al
US$ 21.67
US$ 28.37
US$ 20.05
US$ 29.28
US$ 24.55
US$ 22.32
US$ 28.48
